Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Recent insights into microbial triggers of interleukin-10 production in the host and the impact on infectious disease pathogenesis.

Duell BL, Tan CK, Carey AJ, Wu F, Cripps AW, Ulett GC.

FEMS Immunol Med Microbiol. 2012 Apr;64(3):295-313. doi: 10.1111/j.1574-695X.2012.00931.x. Epub 2012 Feb 14. Review.

2.

Microbial/host interactions in health and disease: who controls the cytokine network?

Henderson B, Poole S, Wilson M.

Immunopharmacology. 1996 Oct;35(1):1-21. Review.

PMID:
8913790
3.

Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu.

Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H.

Cytokine Growth Factor Rev. 2001 Mar;12(1):53-72. Review.

PMID:
11312119
4.

Interleukin-17 as an effector molecule of innate and acquired immunity against infections.

Matsuzaki G, Umemura M.

Microbiol Immunol. 2007;51(12):1139-47. Review.

5.

IL-12 and IL-23: master regulators of innate and adaptive immunity.

Langrish CL, McKenzie BS, Wilson NJ, de Waal Malefyt R, Kastelein RA, Cua DJ.

Immunol Rev. 2004 Dec;202:96-105. Review.

PMID:
15546388
6.

Th17 responses and host defense against microorganisms: an overview.

van de Veerdonk FL, Gresnigt MS, Kullberg BJ, van der Meer JW, Joosten LA, Netea MG.

BMB Rep. 2009 Dec 31;42(12):776-87. Review.

7.

Recognition of microorganisms and activation of the immune response.

Medzhitov R.

Nature. 2007 Oct 18;449(7164):819-26. Review.

PMID:
17943118
8.

CD1 antigen presentation and infectious disease.

Dascher CC, Brenner MB.

Contrib Microbiol. 2003;10:164-82. Review.

PMID:
12530326
9.

Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease outcome.

Biron CA, Gazzinelli RT.

Curr Opin Immunol. 1995 Aug;7(4):485-96. Review.

PMID:
7495512
10.

Attenuation of innate immunity by cytomegalovirus IL-10 establishes a long-term deficit of adaptive antiviral immunity.

Chang WL, Barry PA.

Proc Natl Acad Sci U S A. 2010 Dec 28;107(52):22647-52. doi: 10.1073/pnas.1013794108. Epub 2010 Dec 13.

11.

Interleukin-12 in infectious diseases.

Romani L, Puccetti P, Bistoni F.

Clin Microbiol Rev. 1997 Oct;10(4):611-36. Review.

12.

IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-gamma and nitric oxide synthetase 2.

van Den Broek M, Bachmann MF, Köhler G, Barner M, Escher R, Zinkernagel R, Kopf M.

J Immunol. 2000 Jan 1;164(1):371-8.

13.

[Frontier of mycobacterium research--host vs. mycobacterium].

Okada M, Shirakawa T.

Kekkaku. 2005 Sep;80(9):613-29. Japanese.

PMID:
16245793
14.

Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.

Fehniger TA, Shah MH, Turner MJ, VanDeusen JB, Whitman SP, Cooper MA, Suzuki K, Wechser M, Goodsaid F, Caligiuri MA.

J Immunol. 1999 Apr 15;162(8):4511-20.

15.

Toll-like receptors and their role in host resistance to Toxoplasma gondii.

Yarovinsky F.

Immunol Lett. 2008 Aug 15;119(1-2):17-21. doi: 10.1016/j.imlet.2008.05.007. Epub 2008 Jun 18. Review.

PMID:
18617274
17.

Role of endogenous biological response modifiers in pathogenesis of infectious diseases.

Mullangi PK, Shahani L, Koirala J.

Infect Dis Clin North Am. 2011 Dec;25(4):733-54. doi: 10.1016/j.idc.2011.07.003. Review.

PMID:
22054753
18.

The innate immune response against Brucella in humans.

Dornand J, Gross A, Lafont V, Liautard J, Oliaro J, Liautard JP.

Vet Microbiol. 2002 Dec 20;90(1-4):383-94. Review.

PMID:
12414158
19.
20.

The inflammasome regulatory pathway and infections: role in pathophysiology and clinical implications.

Osawa R, Williams KL, Singh N.

J Infect. 2011 Feb;62(2):119-29. doi: 10.1016/j.jinf.2010.10.002. Epub 2010 Oct 13. Review.

PMID:
20950647

Supplemental Content

Support Center